Go Pro
OTCMKTS:MKGAF

Merck KGaA (MKGAF) Stock Price, News & Analysis

Merck KGaA logo
$155.80 +0.78 (+0.50%)
As of 09:30 AM Eastern

About Merck KGaA Stock (OTCMKTS:MKGAF)

Advanced

Key Stats

Today's Range
$155.80
$155.80
50-Day Range
$153.28
$170.60
52-Week Range
$116.68
$175.56
Volume
57 shs
Average Volume
595 shs
Market Capitalization
$20.14 billion
P/E Ratio
23.79
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The business serves customers in more than 60 countries through three operating sectors: Healthcare, Life Science and Electronics.

The Healthcare sector develops and markets prescription medicines and specialty therapies, with activities focused on areas including oncology, neurology and immunology, fertility, and endocrinology. Its portfolio includes innovative medicines and biologic treatments, as well as products used in reproductive health and other specialized medical applications.

Through its Life Science business, Merck KGaA supplies laboratory products, research tools, analytical technologies, and bioprocessing solutions used in pharmaceutical manufacturing, biotechnology, academia, and industrial research. Its Electronics segment provides materials and technologies for semiconductor manufacturing and display applications, including specialized chemicals, materials, and liquid-crystal technologies.

Merck KGaA operates internationally and conducts research, manufacturing, and commercial activities across Europe, the Americas, Asia, and other global markets. The company is led by Belén Garijo, who serves as chair of the Executive Board and chief executive officer.

AI Generated. May Contain Errors.

Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MKGAF Stock News Headlines

Washington Is Broke—Could YOUR Savings Be Next?
The Department of Justice recently argued in court that cash is not legally property, raising new questions for savers as federal debt continues to climb. Your IRA, 401k, and bank accounts are not hidden from view, prompting some Americans to look for ways to keep more control over their own wealth. A free information kit outlines three strategies people are considering to help shield their savings from future policy changes.tc pixel
See More Headlines

MKGAF Stock Analysis - Frequently Asked Questions

Merck KGaA's stock was trading at $147.60 at the start of the year. Since then, MKGAF shares have increased by 8.1% and is now trading at $159.5830.

Merck KGaA's top institutional shareholders include Bank of America Corp DE (23.63%), Legal & General Group Plc (14.60%), Barrow Hanley Mewhinney & Strauss LLC (5.67%) and Caisse de depot et placement du Quebec (3.44%).

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/10/2026
Next Earnings (Estimated)
11/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
62,908
Year Founded
1891

Profitability

EPS (Trailing Twelve Months)
$6.81
Trailing P/E Ratio
24.36
Forward P/E Ratio
16.37
P/E Growth
N/A
Net Income
$3.06 billion
Net Margins
12.60%
Pretax Margin
15.64%
Return on Equity
10.17%
Return on Assets
5.74%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
1.31
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$22.72 billion
Price / Sales
0.91
Cash Flow
$48.07 per share
Price / Cash Flow
3.32
Book Value
$212.00 per share
Price / Book
0.75

Miscellaneous

Outstanding Shares
129,240,000
Free Float
N/A
Market Cap
$20.62 billion
Optionable
Not Optionable
Beta
0.96

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:MKGAF) was last updated on 9/10/2026 by MarketBeat.com Staff.
From Our Partners